|
Exosomes Proteomic for Sjogren's Syndrome and Dry Eye Syndrome
RECRUITINGSponsored by Taipei Veterans General Hospital, Taiwan
Actively Recruiting
SponsorTaipei Veterans General Hospital, Taiwan
Started2025-01-16
Est. completion2025-04-30
Eligibility
Age20 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06771427
Summary
By analyzing the differential proteins in exosomes, this study aims to understand the pathological mechanisms of SJS and DES, identify potential diagnostic and therapeutic methods, and advance the diagnosis and treatment of these diseases.
Eligibility
Age: 20 Years – 75 YearsHealthy volunteers accepted
Dry eye syndrome Inclusion Criteria: aged between 20 and 75 years Schirmer's test less than 10 mm/5 min Exclusion Criteria: Pregnancy With eye inflammation or infectious eye disease Accepted operation of eye Sjögren's syndrome Inclusion Criteria: primary or secondary SS aged between 20 and 75 years fulfilled the 2002 American-European Consensus Criteria for SS (AECG) had no abnormal findings of immune, liver, kidney, or blood function evaluations. Exclusion Criteria: a history of alcohol abuse, diabetes mellitus, or major life-threatening condition pregnancy or breastfeeding steroid pulse therapy within three months prior to the commencement of our study. non AIDDES Healthy Controls Inclusion Criteria: aged between 20 and 75 years without any Chronic disease Exclusion Criteria: any Sjögren's syndrome or Dry eye syndrome.
Conditions4
ArthritisDry Eye Syndrome (DES)Sjogren's SyndromeXerophthalmia
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorTaipei Veterans General Hospital, Taiwan
Started2025-01-16
Est. completion2025-04-30
Eligibility
Age20 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06771427